| Product Information |
|
| Registration Number |
DRP-15770
|
| Generic Name |
Doxorubicin hydrochloride
|
| Brand Name |
Adrycin
|
| Dosage Strength |
2 mg/mL (20 mg/10 mL)
|
| Dosage Form |
Pegylated Liposomal Concentrate Suspension for Injection (I.V. Infusion)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antineoplastic Agent (Anthracycline)
|
| Packaging |
USP Type I glass vial with gray color rubber stopper and white color flip off seal x 10 mL (Box of 1's)
|
| Manufacturer |
Hetero Labs Limited (Unit VI)
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
Camber Pharmaceuticals, Inc.
|
| Distributor |
Camber Pharmaceuticals, Inc.
|
| Application Type |
Initial
|
| Issuance Date |
12 September 2024
|
| Expiry Date |
12 September 2029
|